Annals

Next Generation Sequencing (NGS) testing has gained significant importance in the medical clinical laboratory in the United States over the past decade. In recent years, the field of molecular diagnostics has witnessed significant advancements...

As 2023 draws to a close, Eurofins Viracor, a leading infectious disease testing laboratory, takes a moment to reflect on the significant milestones and advancements achieved throughout the year. With a commitment to delivering cutting-edge diagnostic solutions, Eurofins Viracor has continued to push the boundaries of infectious disease testing...

Nontuberculous mycobacteria (NTM) refer to all the species in the family of mycobacteria that may cause human disease, but do not cause tuberculosis (MTB) or leprosy. In a U.S. study from 2010, it was estimated that approximately 30 people per 100,000 population were infected with these lesser-known species of MTB and leprosy.

In the field of immunology, monitoring natural killer (NK) cell activity plays a crucial role in assessing and understanding the body's immune response. Medical professionals play a pivotal role in advancing patient care and ensuring accurate diagnostics. This post aims to provide you with valuable insights into the significance of natural killer cell activity...

In the realm of healthcare, infectious diseases pose significant challenges worldwide. The ability to accurately diagnose and monitor infectious diseases is crucial for effective patient management and public health interventions. Viracor, a leading infectious disease testing laboratory, has been at the forefront of innovation, continuously advancing testing capabilities to provide reliable and comprehensive solutions.

September marks a significant month in raising awareness for leukemia and lymphoma, two types of blood cancers that affect thousands of individuals worldwide. Eurofins Viracor proudly joins the cause during Leukemia and Lymphoma Awareness Month...

September is National Childhood Cancer Awareness Month, a time dedicated to raising awareness and supporting children and families affected by this devastating disease. Eurofins Viracor is proud to be at the forefront of pediatric cancer testing, offering advanced diagnostic solutions to improve outcomes for children battling leukemia. Our ExPeCT^TM CAR T test plays a crucial role in monitoring pediatric CAR T-cell therapy...

When it comes to CAR T-cell therapy for pediatric patients, several factors need to be considered during laboratory testing to ensure optimal treatment outcomes. These considerations include the unique biological characteristics of pediatric patients, the specific types of cancers prevalent in this population, and the potential impact of prior treatments. While CAR T-cell therapy offers promising outcomes...

Comprehensive CMV testing is a crucial tool in the management of cytomegalovirus infections. It enables early diagnosis, facilitates appropriate treatment interventions, and aids in optimizing patient outcomes. By implementing comprehensive CMV testing protocols, healthcare providers can effectively assess, treat, and manage CMV infections, ultimately improving the quality of care for affected individuals...

Invasive fungal diseases (IFDs) are a serious and often life-threatening group of infections caused by fungi that invade tissues and organs. These infections can be serious and even fatal, especially in people who are immunocompromised. These diseases are becoming increasingly common, especially in people with weakened immune systems due to diseases such as HIV/AIDS, cancer, and organ transplantation...